{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-009142","form_type":"8-K","ticker":"ACUT","cik":"0001850767","company_name":"Accustem Sciences Inc.","filed_at":"2022-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.859761+00:00","generated_at":"2026-06-26T09:33:51.132509+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AccuStem Sciences sells 1.34M shares to Tiziana Life Sciences at $2.00/sh, raising $2.68M; CEO also joins board","bullets":["Tiziana Life Sciences purchased 1,337,970 shares of AccuStem common stock at $2.00 per share for gross proceeds of $2,675,940.","Sale was pursuant to a Supplemental Demerger Agreement from Oct 2021, requiring Tiziana to buy £2M shares at listing.","Shares are unregistered and offered under Regulation S exemption.","CEO Wendy Blosser appointed to the Board of Directors, effective March 30, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-009142","json":"https://secwatch.observer/filing/0001493152-22-009142.json","markdown":"https://secwatch.observer/filing/0001493152-22-009142.md","text":"https://secwatch.observer/filing/0001493152-22-009142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/0001493152-22-009142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:33:51.132509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c35a945cf","claim":"Wendy Blosser was appointed as director at Accustem Sciences Inc..","evidence_excerpt":"On March 30, 2022, the Board of Directors of the Company appointed Wendy Blosser, the Company’s Chief Executive Officer as a director to serve on the Board and to hold office until the next annual meeting of stockholders and until her successor is duly elected and qualified","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/0001493152-22-009142-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}